Teva Pharmaceutical Industries (TEVA) Liabilities from Discontinued Operations (2017)
Teva Pharmaceutical Industries' (TEVA) quarterly Liabilities from Discontinued Operations came in at 38000000.0 in Q4 2017.
Teva Pharmaceutical Industries (TEVA) Liabilities from Discontinued Operations (2017) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 38000000.0 in Q4 2017.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 38000000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was 38000000.0 (changed N/A YoY) and the FY2017 annual result came in at 38000000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations was little changed at 38000000.0 in Q4 2017.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 38000000.0 in Q4 2017 to a low of 38000000.0 in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 38.00 Mn |
| Dec 31, 2017 | 38.00 Mn |